Craft

Concord Medical

Stock Price

$7.4

2024-10-29

Market Capitalization

$32.3 M

2024-10-29

Revenue

¥460.5 M

FY, 2025

Concord Medical Summary

Company Summary

Overview
Concord Medical (CCM, 泰和诚医疗集团) is a company that operates a network of cancer hospitals, as well as radiotherapy and diagnostic imaging centers. It offers services including radiotherapy, gamma knife radiosurgery, ultrasound therapy, diagnostic imaging, thermotherapy for pain relief after radiotherapy and chemotherapy, etc. In addition, the company provides electroencephalography for the diagnosis of epilepsy, stereotactic radiofrequency ablation for the treatment of Parkinson's disease, and refraction and tonometry for the diagnosis of ophthalmic conditions.
Type
Public
Status
Active
Founded
1997
HQ
Beijing, CN | view all locations
Website
http://www.concordmedical.com/
Cybersecurity rating
ESG rating
30-39 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Beijing, Bei Jing Shi HQ

    China

    Huan Qiu Mao Yi Zhong Xin, 亮马桥 Dong Cheng Qu

Concord Medical Financials

Summary Financials

Revenue (FY, 2025)
¥460.5M
Gross profit (FY, 2025)
¥165.4M
Net income (FY, 2025)
(¥379.4M)
Cash (FY, 2025)
¥297.8M
EBIT (FY, 2025)
(¥234.0M)
Enterprise value
$3.6B

Footer menu